Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial

Allan Musinguzi, Joan R. Kasidi, Jillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T. Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A. Berger, Hélène E. Aschmann, Payam Nahid, Robert Belknap, Moses R. Kamya, Margaret A. Handley, Patrick PJ Phillips, Noah Kiwanuka, Achilles Katamba, David W. Dowdy, Adithya Cattamanchi, Fred C. Semitala, Anne R. Katahoire
doi: https://doi.org/10.1101/2024.08.19.24308041

Data Availability

All data produced in the present study are available upon reasonable request to the authors with the necessary editing to preserve participant anonymity.

Back to top
Posted August 22, 2024.
Download PDF
Data/Code
Email
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
Allan Musinguzi, Joan R. Kasidi, Jillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T. Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A. Berger, Hélène E. Aschmann, Payam Nahid, Robert Belknap, Moses R. Kamya, Margaret A. Handley, Patrick PJ Phillips, Noah Kiwanuka, Achilles Katamba, David W. Dowdy, Adithya Cattamanchi, Fred C. Semitala, Anne R. Katahoire
medRxiv 2024.08.19.24308041; doi: https://doi.org/10.1101/2024.08.19.24308041
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area